Annals Consult Guys - Cancer and Deep Venous Thrombosis: A Serious Combination
Authors: Geno J. Merli, Howard H. Weitz
Journal: Annals of Internal Medicine (2021)

Web ExclusivesJanuary 2021Annals Consult Guys - Cancer and Deep Venous Thrombosis: A Serious CombinationFREEhas associated examAnnals Consult Guys - Cancer and Deep Venous Thrombosis: A Serious CombinationFREEGeno J. Merli, MD, Howard H. Weitz, MDGeno J. Merli, MDThomas Jefferson University, Philadelphia, Pennsylvania (G.J.M., H.H.W.), Howard H. Weitz, MDThomas Jefferson University, Philadelphia, Pennsylvania (G.J.M., H.H.W.)Author, Article and Disclosure Informationhttps://doi.org/10.7326/W20-0017 CME/MOC SectionsSupplemental MaterialAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode. the Consult Guys discuss the management of patients with cancer and deep venous thrombosis.For more videos from and information on Annals Consult Guys, visit go.annals.org/ConsultGuys. Comments0 CommentsSign In to Submit A Comment Francis CajfingerDit of Medical Oncology,Hopital de la Salpetriere ,Paris,France31 January 2021 Uncertainty Although very interesting, this discussion between 2 eminent physicians left me with a better note. In other words, it seems that the DOAC are becoming the initial treatment of CAT instead of LMWH. In this case, we know nothing about the cancer treatment of this patient. May I remind everyone that there are interactions between some cancer treatments and the DOAC. It is our policy in the department and at the ER not to prescribe DOAC at the initial phase without all the details about meds, otherwise, we will face problems to say the least in the future. These are not simple meds and we have to be careful. Jeffrey BrensilverSt George's U. School of Med23 January 2021 Clinical non-resolution of DVT In this high risk cancer associated hypercoagulable patient, should the persistence of venous occlusion prompt any further imaging or change n Rx? We know that failure to recanalize represents a higher risk for recurrence. Arthur R Ersner, MD, FACP. TJUH Internal Medicine Resident Class ot 1979Einstein Medical Center Montgomery19 January 2021 Cancer and DVT Drs., Excellent and concise review of this common problem. Thanks, Art Ersner Author, Article and Disclosure InformationDisclosures: Geno J. Merli, MD, and Howard H. Weitz, MD, report that they have no financial relationships or interests to disclose.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Stephanie Chang, MD, MPH, Deputy Editor, reports employment with the Agency for Healthcare Research and Quality, travel compensation from the Guidelines International Network, and participation in the Patient-Centered Outcomes Research Institute methodology committee. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interests to disclose. Eliseo Guallar, MD, MPH, DrPH, Deputy Editor, Statistics, reports that he has no financial relationships or interests to disclose. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics January 2021Volume 174, Issue 1Page: CG1 ePublished: 19 January 2021 Issue Published: January 2021 CopyrightCopyright © 2021 by American College of Physicians. All Rights Reserved.Loading ...